Eli Lilly's weight ... dual GIP/GLP-1 receptor agonist will initially be offered only to around 220,000 people with the highest clinical need, according to NICE, which stressed that Mounjaro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback